Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

Market Cap	6.21B +17.7%
Revenue (ttm)	1.39B +30.4%
Net Income	251.99M +21.4%
EPS	1.41 +11.8%
Shares Out	211.20M
PE Ratio	20.91
Forward PE	n/a
Dividend	0.26 (0.88%)
Ex-Dividend Date	Jun 3, 2026

Volume	4,600
Open	29.52
Previous Close	29.42
Day's Range	29.40 - 29.52
52-Week Range	27.86 - 41.40
Beta	-0.13
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 24, 2026

About HKG:1501

Shanghai INT Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. It offers transradial and femoral pressure bandage, hydrophilic guidewire, pressure Y-connector set, PTFE guidewire, PTCA balloon dilatation catheter, noncompliant balloon dilatation catheter, compression femoral artery tourniquet, vascular sheaths for single use, push-to-thread balloon dilatio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2006
• Employees: 2,180
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1501

Financial Performance

In 2025, HKG:1501's revenue was 1.07 billion, an increase of 25.06% compared to the previous year's 851.95 million. Earnings were 206.23 million, an increase of 13.99%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error